These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16467371)

  • 41. Effect of the statin atorvastatin on intracellular signalling by the prostacyclin receptor in vitro and in vivo.
    O'Meara SJ; Kinsella BT
    Br J Pharmacol; 2004 Sep; 143(2):292-302. PubMed ID: 15326037
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Atorvastatin reduces long pentraxin 3 expression in vascular cells by inhibiting protein geranylgeranylation.
    Baetta R; Lento S; Ghilardi S; Barbati E; Corsini A; Tremoli E; Banfi C
    Vascul Pharmacol; 2015; 67-69():38-47. PubMed ID: 25849951
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Atorvastatin reduces the expression of prostaglandin E2 receptors in human carotid atherosclerotic plaques and monocytic cells: potential implications for plaque stabilization.
    Gómez-Hernández A; Sánchez-Galán E; Martín-Ventura JL; Vidal C; Blanco-Colio LM; Ortego M; Vega M; Serrano J; Ortega L; Hernández G; Tunón J; Egido J
    J Cardiovasc Pharmacol; 2006 Jan; 47(1):60-9. PubMed ID: 16424787
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Atorvastatin suppresses aldosterone-induced neonatal rat cardiac fibroblast proliferation by inhibiting ERK1/2 in the genomic pathway.
    Wang Q; Cui W; Zhang HL; Hu HJ; Zhang YN; Liu DM; Liu J
    J Cardiovasc Pharmacol; 2013 Jun; 61(6):520-7. PubMed ID: 23429584
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of protein geranylgeranylation specifically interferes with CD40-dependent B cell activation, resulting in a reduced capacity to induce T cell immunity.
    Shimabukuro-Vornhagen A; Zoghi S; Liebig TM; Wennhold K; Chemitz J; Draube A; Kochanek M; Blaschke F; Pallasch C; Holtick U; Scheid C; Theurich S; Hallek M; von Bergwelt-Baildon MS
    J Immunol; 2014 Nov; 193(10):5294-305. PubMed ID: 25311809
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a 'mitohormesis' mechanism involving reactive oxygen species and PGC-1.
    Bouitbir J; Charles AL; Echaniz-Laguna A; Kindo M; Daussin F; Auwerx J; Piquard F; Geny B; Zoll J
    Eur Heart J; 2012 Jun; 33(11):1397-407. PubMed ID: 21775390
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Atorvastatin upregulates the expression of PPAR alpha/gamma and inhibits the hypertrophy of cardiac myocytes in vitro].
    Sheng L; Ye P; Liu YX
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Dec; 33(12):1080-4. PubMed ID: 16563274
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Atorvastatin attenuates TNF-α-induced increase of glucose oxidation through PGC-1α upregulation in cardiomyocytes.
    Gao F; Ni Y; Luo Z; Liang Y; Yan Z; Xu X; Liu D; Wang J; Zhu S; Zhu Z
    J Cardiovasc Pharmacol; 2012 Jun; 59(6):500-6. PubMed ID: 22343369
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin.
    Dunn SE; Youssef S; Goldstein MJ; Prod'homme T; Weber MS; Zamvil SS; Steinman L
    J Exp Med; 2006 Feb; 203(2):401-12. PubMed ID: 16476765
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Atorvastatin, but not pravastatin, inhibits cardiac Akt/mTOR signaling and disturbs mitochondrial ultrastructure in cardiac myocytes.
    Godoy JC; Niesman IR; Busija AR; Kassan A; Schilling JM; Schwarz A; Alvarez EA; Dalton ND; Drummond JC; Roth DM; Kararigas G; Patel HH; Zemljic-Harpf AE
    FASEB J; 2019 Jan; 33(1):1209-1225. PubMed ID: 30169110
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Atorvastatin improves peroxisome proliferator-activated receptor signaling in cardiac hypertrophy by preventing nuclear factor-kappa B activation.
    Planavila A; Laguna JC; Vázquez-Carrera M
    Biochim Biophys Acta; 2005 Feb; 1687(1-3):76-83. PubMed ID: 15708355
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Atorvastatin inhibits angiotensin-converting enzyme induction in differentiating human macrophages.
    Saijonmaa O; Nyman T; Fyhrquist F
    Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1917-21. PubMed ID: 17158648
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of atorvastatin on heart mitochondrial function and coenzyme Q content in the experiment.
    Kucharska J; Ulicna O; Gvozdjakova A; Vancova O; Waczulikova I; Bozek P; Bada V
    Bratisl Lek Listy; 2011; 112(11):603-4. PubMed ID: 22180983
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Atorvastatin inhibits T cell activation through 3-hydroxy-3-methylglutaryl coenzyme A reductase without decreasing cholesterol synthesis.
    Blank N; Schiller M; Krienke S; Busse F; Schätz B; Ho AD; Kalden JR; Lorenz HM
    J Immunol; 2007 Sep; 179(6):3613-21. PubMed ID: 17785796
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Atorvastatin inhibits CXCR7 induction to reduce macrophage migration.
    Ma W; Liu Y; Wang C; Zhang L; Crocker L; Shen J
    Biochem Pharmacol; 2014 May; 89(1):99-108. PubMed ID: 24582769
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Statins reduce amyloid-beta production through inhibition of protein isoprenylation.
    Ostrowski SM; Wilkinson BL; Golde TE; Landreth G
    J Biol Chem; 2007 Sep; 282(37):26832-26844. PubMed ID: 17646164
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevention of transplant coronary artery disease by prenylation inhibitors.
    Stein W; Schrepfer S; Itoh S; Kimura N; Velotta J; Palmer O; Bartos J; Wang X; Robbins RC; Fischbein MP
    J Heart Lung Transplant; 2011 Jul; 30(7):761-9. PubMed ID: 21458297
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of beta-hydroxy-beta-methylglutaryl coenzyme A reductase inhibitor atorvastatin on contractility of the isolated rat heart under normal conditions and during oxidative stress.
    Lakomkin VL; Kapel'ko VI; Lankin VZ; Konovalova GG; Kaminnyi AI
    Bull Exp Biol Med; 2007 Apr; 143(4):408-10. PubMed ID: 18214286
    [TBL] [Abstract][Full Text] [Related]  

  • 59. G protein betagamma dimer expression in cardiomyocytes: developmental acquisition of Gbeta3.
    Rybin VO; Steinberg SF
    Biochem Biophys Res Commun; 2008 Apr; 368(2):408-13. PubMed ID: 18242165
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Atorvastatin reduces cardiac and adipose tissue inflammation in rats with metabolic syndrome.
    Yamada Y; Takeuchi S; Yoneda M; Ito S; Sano Y; Nagasawa K; Matsuura N; Uchinaka A; Murohara T; Nagata K
    Int J Cardiol; 2017 Aug; 240():332-338. PubMed ID: 28499669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.